Eli Lilly and Company -

Links shared publicly online about this topic.

  • 1,757
    total visits

Eli Lilly and Company -

newsroom.lilly.com

Eli Lilly and Company -

View full resource at newsroom.lilly.com

Tags: Pain, Back Pain, Eli Lilly and Company

  • Share

Most Recently Shared on September 11, 2009 at 2:28 pm By:

eyeonfda eyeonfda

New Lilly Data Show Patients With Chronic Low Back Pain on Cymbalta(R) http://bit.ly/bPvoX

3 years ago...

Why Eli Lilly's Alzheimer's Imaging Test Is No Breakthrough - Forbes

forbes.com — “Why the new Alzheimer's test is only a baby step toward early detection.View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on April 9, 2012 at 5:06 pm By:

Diagnostic_Test Diagnostic_Test OW Health

Why Eli Lilly's Alzheimer's Imaging Test Is No Breakthrough: Sometimes (not always, certainly, but sometimes), M... http://t.co/VwznkQ5L

2 weeks ago...

FDA Approves Alzheimer's Test Developed by Eli Lilly - WSJ.com

online.wsj.com — “The FDA approved an Eli Lilly test that can help detect Alzheimer's—a potential boon to treatment and developing drugs against the disease.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on April 8, 2012 at 11:34 pm By:

U.S. gives nod to Eli Lilly's brain plaque test | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer's disease, the company said.TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 8, 2012 at 3:30 am By:

Lilly says FDA approves brain imaging agent - Yahoo! News

news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said late Friday that the Food and Drug Administration approved Amyvid, a diagnostic imaging agent that is intended to help diagnose Alzheimer's disease.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 7, 2012 at 11:39 pm By:

Diagnostic_Test Diagnostic_Test OW Health

Lilly says FDA approves brain imaging agent: Eli Lilly and Co. said late Friday that the Food and Drug Administr... http://t.co/KiJpJNHt

3 weeks ago...

NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH

highlighthealth.com — “The National Institutes of Health and Eli Lilly and Company announced that they will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines.View full resource at highlighthealth.com

  • View Related
  • Share

Most Recently Shared on April 2, 2012 at 6:45 pm By:

HighlightHEALTH Walter Jessen - Highlight HEALTH Health Organization and Health Executive

NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive http://t.co/9JS7R7oK

3 weeks ago...

Eli Lilly says psoriasis drug meets goal in study - Yahoo! News

news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said Wednesday its experimental psoriasis drug met its goals in a mid-stage clinical trial.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 2:20 am By:

Psoriasis_OW Psoriasis OW OW Health

Eli Lilly says psoriasis drug meets goal in study: Eli Lilly and Co. said Wednesday its experimental psoriasis d... http://t.co/QtU8mxce

4 weeks ago...

Byetta cleared for add-on therapy with basal insulin in EU | BioPortfolio.com

bioportfolio.com — “From BioPortfolio: US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN) and drug major Eli Lilly (NYSE: LLY) said on Friday that the European Commission has granted marketing aut...View full resource at bioportfolio.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 9:37 am By:

BioPortfolio BioPortfolio Health News

BioPortfolio News Byetta cleared for addon therapy with basal insulin in EU: US biotech firm A... http://t.co/JKCjSA5t BioPortfolio News

4 weeks ago...

Eli Lilly and Company - BYETTA® Approved for Use with Basal Insulin in Europe

newsroom.lilly.com — “Eli Lilly and Company - BYETTA® Approved for Use with Basal Insulin in EuropeView full resource at newsroom.lilly.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 6:43 pm By:

Glycosmedia Jim Health News

BYETTA® Approved for Use with Basal Insulin in Europe (Lilly) http://t.co/W8GNvepK

1 month ago...

European Commission grants marketing authorization for use of BYETTA with basal insulin

news-medical.net — “Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:57 pm By:

NewsMedical News-Medical.Net Health News

European Commission grants marketing authorization for use of BYETTA with basal insulin: Amylin Pharmaceuticals,... http://t.co/3EqmxLdM

1 month ago...

Pfizer, Lilly and Sanofi help authorities break up counterfeiters - FiercePharma Manufacturing

fiercepharmamanufacturing.com — “A gang believed to be importing fake drugs from Asia, including erectile dysfunction drug knockoffs, has been intercepted by authorities with the help of Pfizer ($PFE), Eli Lilly ($LLY) and Sanofi ( Read more...View full resource at fiercepharmamanufacturing.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 4:20 pm By:

Lilly to focus on diabetes, cancer in China - FiercePharma

fiercepharma.com — “Eli Lilly ($LLY) has a plan to maintain sales growth, and it involves China, a big prize drugmakers having been eyeing over the last several years. CEO John Lechleiter (photo) wants Lilly to be the Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 4:31 pm By:

FiercePharma FiercePharma Health Site

Lilly to focus on diabetes, cancer in China - FiercePharma: http://t.co/R5xx10IG via @AddThis

1 month ago...

Champion of My Heart » Blog Archive » Dog Blog Poll: Should a Vaccine Company Help Cover Costs When Vaccines Cause Expensive Outcomes?

championofmyheart.com — “Please take our dog blog poll about adverse vaccine reactions in dogs. Lilly, a border collie and the canine heroine of award-winning dog blog Champion of My Heart, developed meningoencephalomyelitis / meningoencephalitis (inflammation of the brain and lining of the brain and spinal cord) after an adverse reaction to a rabies vaccine given January 23, 2012.View full resource at championofmyheart.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 11:47 am By:

DawgBlogger Jana Rade Pet Health Advocate

Dog Blog Poll: Should a Vaccine Company Help Cover Costs When Vaccines Cause Expensive Outco... http://t.co/DwnFpr6q via @champofmyheart

1 month ago...

Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism

eurekalert.org — “European Autism Interventions ? A Multicentre Study for Developing New Medications led by Roche, King's College London, and Autism Speaks, is a collaboration with top scientists worldwide and drug companies from EFPIA including Roche, Eli Lilly, Servier, Janssen Pharmaceutica, Pfizer and Vifor Pharma to develop and validate translational research approaches for novel therapies; develop expert sites across Europe to run clinical trials; and create an interactive platform for ASD professionals andView full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 1:24 pm By:

Autism_Wisdom Autism OW OW Health

Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism: ( Autism Speaks )... http://t.co/4TW6Jdtc

1 month ago...

Ex-Google exec says social media obsession is unraveling the company | Death and Taxes

deathandtaxesmag.com — “Ex-Google exec says social media obsession is unraveling the company | Death and TaxesView full resource at deathandtaxesmag.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 3:52 pm By:

drrobsSheely Chiropractic Clinic is a modern health care facility that specializes in providing treatment for chronic and difficult conditions of the neuro – musculo – skeletal system. The Clinic maintains a 24-hour emergency message and scheduling center, and provides current “managed care model’ type case management for all conditions treated in the clinic. Statistics of the effectiveness of patient outcomes are constantly monitored through the clinic’s eight networked computer work stations. 

Patients are treated using “state-of-the-art” equipment and techniques, including cryotherapy, hydrocollator therapy, electrical muscle stimulation therapy, interferrential therapy, russian stimulation, ultrasound therapy, motorized intersegmental mobilization and distraction therapy, muscle rehabilitation with exercise education instructions, and specific skilled manipulation (adjustments) of the spine and joints of the body. Nutritional and lifestyle counseling is a frequently requested service and is provided considering individual goals and needs. Patients are cared for by trained, efficient, and qualified staff, who are both friendly and professional.

As the Clinic Director of Sheely Chiropractic Clinic, Dr. Sheely is responsible for overseeing all aspects of program development, staff supervision, and the provision of chiropractic care. Sheely Chiropractic Clinic has been providing service since 1980, and currently employs a staff of four." /> Dr. Robert B. Sheely CAM, Chiropractor, Active Health Library, and Doctor

Ex-Google exec says social media obsession is unraveling the company http://t.co/6EliH507

1 month ago...

NIH and Lilly to generate public resource of approved and investigational medicines, March 13, 2012 News Release - National Institutes of Health (NIH)

nih.gov — “The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.View full resource at nih.gov

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 5:13 pm By:

FasterCures FasterCures Health Organization

#NCATS#pharmaceutical collection of 3,800 approved & investigational meds 2 B screened w/ #Lilly’s PD2 assay panel http://t.co/7sf29RY3

1 month ago...

Advertisement